GSK3B and colorectal carcinoma: As shown in Fig. 3A, β-catenin, phospho-β-catenin (Ser33/Ser37/Thr41), and phospho-GSK3β (Ser9) protein expression levels were increased, while phospho-β-catenin (Ser33/Ser37/Thr41) and phospho-GSK3β (Ser9) levels were decreased by BMX treatment in three CRC cell lines.